Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 84
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Good growth
Data is available to registered users only
Data is available to registered users only
About
Aplus Biotechnology Corporation Limited engages in the development of orthopedic trauma medical equipment products. The company is based in New Taipei City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Data is available to registered users only
Buy
Sell